Neurofibromatosis 2 in a patient with a de novo balanced reciprocal translocation 46,X,t(X;22)(p11.2;q11.2)

Journal of Medical Genetics

Volumn 40, Issue 9, 2003, Pages 682-684

  Bovie, C ^a   Holden, S T ^a   Schroer, A ^a   Smith, E ^b   Trump, D ^a   Raymond, F L ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 22; CLINICAL FEATURE; DNA ISOLATION; FEMALE; GENE LIBRARY; GENE TRANSLOCATION; HOSPITALIZATION; HUMAN; MOLECULAR CLONING; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0041829013     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.9.682     Document Type: Article

References (16)

1. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;75:826.
2. Conference NCD. Neurofibromatosis conference statement. Arch Neurology 1988;45:575-8.
3. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-7.
4. Baser ME, Friedman JM, Wallace AJ, et al. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 2002;59:1759-65.
5. Allen RC, Zoghbi HY, Moseley AB, et al. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
6. Woffendin H, Jakins T, Jouet M, et al. X-inactivation and marker studies in three families with incontinentia pigmenti: implications for counselling and gene localisation. Clin Genet 1999;55:55-60.
7. Cox JJ, Holden ST, Dee S, et al. Identification of a 650 kb duplication at the X chromosome breakpoint in a patient with 46,X,t(X;8)(q28;q12) and non-syndromic mental retardation. J Med Genet 2003;40:169-74.
8. Zucman-Rossi J, Legoix P, Der Sarkissian H, et al. NF2 gene in neurofibromatosis type 2 patients. Hum Mol Genet 1998;7:2095-101.
9. Schmidt M, Du Sart D. Functional disomies of the X chromosome influence the cell selection and hence the X inactivation pattern in females with balanced X-autosome translocations: a review of 122 cases. Am J Med Genet 1992;42:161-9.
10. Cross HE, Hansen RC, Morrow G 3rd, et al. Retinoblastoma in a patient with a 13qXp translocation. Am J Ophthalmol 1977;84:548-54.
11. Ejima Y, Sasaki MS, Kaneko A, et al. Possible inactivation of part of chromosome 13 due to 13qXp translocation associated with retinoblastoma. Clin Genet 1982;21:357-61.
12. Kajii T, Tsukahara M, Fukushima Y, et al. Translocation (X;13)(p11.21;q12.3) in a girl with incontinentia pigmenti and bilateral retinoblastoma. Ann Genet 1985;28:219-23.
13. Nichols WW, Miller RC, Sobel M, et al. Further observations on a 13qXp translocation associated with retinoblastoma. Am J Ophthalmol 1980;89:621-7.
14. Ponzio G, Savin E, Cattaneo G, et al. Translocation X;13 in a patient with retinoblastoma. J Med Genet 1987;24:431-4.
15. Stambolian D, Sellinger B, Derrington D, et al. Cytogenetic and molecular investigation of a balanced Xq13q translocation in a patient with retinoblastoma. Am J Med Genet 1992;42:771-6.
16. Jones C Booth C, Rita D, et al. Bilateral retinoblastoma in a male patient with an X; 13 translocation: evidence for silencing of the RB1 gene by the spreading of X inactivation. Am J Hum Genet 1997;60:1558-62.